Price
$0.48
Decreased by -2.45%
Dollar volume (20D)
271.85 K
ADR%
10.39
Earnings report date
May 12, 2025
Shares float
61.37 M
Shares short
2.06 M [3.36%]
Shares outstanding
82.69 M
Market cap
55.04 M
Beta
1.65
Price/earnings
N/A
20D range
0.45 0.70
50D range
0.45 0.95
200D range
0.45 1.70

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.

It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients.

The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma.

It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma.

The company was founded in 2014 and is based in Boston, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 17, 25 -0.32
Increased by +53.62%
-0.35
Increased by +9.86%
Nov 6, 24 -0.34
Increased by +70.69%
-0.34
Aug 8, 24 -0.33
Increased by +56.01%
-0.36
Increased by +8.36%
May 14, 24 -0.35
Increased by +51.39%
-0.39
Increased by +10.26%
Mar 19, 24 -0.69
Increased by +4.17%
-0.69
Nov 8, 23 -1.16
Decreased by -118.87%
-0.74
Decreased by -56.76%
Aug 9, 23 -0.75
Decreased by -33.93%
-0.68
Decreased by -10.29%
May 9, 23 -0.72
Decreased by -820.00%
-0.69
Decreased by -4.35%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 0.00
Decreased by -100.00%
-28.73 M
Increased by +2.58%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-30.48 M
Increased by +38.90%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-29.90 M
Increased by +7.72%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-28.02 M
Increased by +5.44%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 12.89 M
Increased by +151.60%
-29.49 M
Decreased by -4.93%
Decreased by -228.70%
Decreased by -303.37%
Sep 30, 23 0.00
Decreased by N/A%
-49.88 M
Decreased by -137.47%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-32.40 M
Decreased by -44.86%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by -100.00%
-29.63 M
Decreased by -741.55%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY